Skip to main content
SleepCited
Figure 2
Figure 2.

Gender distribution of participants among treatment groups. T1: Placebo (starch tablets 250 mg × 2). T2: Magnesium (250 mg × 2). T3: Potassium (250 mg × 2). T4: Magnesium + potassium (250 mg × 2).

Description

Sleep quality assessment data from participants receiving magnesium and potassium supplementation, using validated insomnia rating scales or polysomnography measures.

Cite This Figure

![Figure 2: Sleep quality assessment data from participants receiving magnesium and potassium supplementation, using validated insomnia rating scales or polysomnography measures.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554482/bin/fendo-15-1370733-g002.jpg)

> Source: Sidra Khalid et al. "Effects of magnesium and potassium supplementation on insomnia and sleep hormone." *Frontiers in endocrinology*, 2024. PMID: [39534260](https://pubmed.ncbi.nlm.nih.gov/39534260/)
<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554482/bin/fendo-15-1370733-g002.jpg" alt="Sleep quality assessment data from participants receiving magnesium and potassium supplementation, using validated insomnia rating scales or polysomnography measures." />
  <figcaption>Figure 2. Sleep quality assessment data from participants receiving magnesium and potassium supplementation, using validated insomnia rating scales or polysomnography measures.<br>  Source: Sidra Khalid et al. "Effects of magnesium and potassium supplementation on insomnia and sleep hormone." <em>Frontiers in endocrinology</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39534260/">39534260</a></figcaption>
</figure>